Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer

被引：0
|
作者：
Ravdin, PM
机构：
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：18 / 21
页数：4
相关论文
共 50 条
  • [1] Docetaxel in patients with anthracycline-resistant advanced breast cancer
    Vici, P
    Belli, F
    Di Lauro, L
    Amodio, A
    Conti, F
    Foggi, P
    Gionfra, T
    Morelli, MF
    Botti, C
    Ferraironi, A
    Lopez, M
    [J]. ONCOLOGY, 2001, 60 (01) : 60 - 65
  • [2] Anthracycline-resistant breast cancer
    Gabriel N. Hortobagyi
    Xavier Pivot
    Lina Asmar
    [J]. Breast Cancer, 1997, 4 (4) : 221 - 227
  • [3] The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-resistant breast cancer (Review)
    Pivot, X
    Asmar, L
    Hortobagyi, GN
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (02) : 381 - 386
  • [4] Current options in treatment of anthracycline-resistant breast cancer
    Kröger, N
    Achterrath, W
    Hegewisch-Becker, S
    Mross, K
    Zander, AR
    [J]. CANCER TREATMENT REVIEWS, 1999, 25 (05) : 279 - 291
  • [5] Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer
    Huang, E
    McNeese, MD
    Strom, EA
    Perkins, GH
    Katz, A
    Hortobagyi, GN
    Valero, V
    Kuerer, HM
    Singletary, SE
    Hunt, KK
    Buzdar, AU
    Buchholz, TA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05): : 1225 - 1233
  • [6] Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer
    Brodowicz, T
    Koestler, WJ
    Tomek, S
    Vaclavik, I
    Herscovici, V
    Wiltschke, C
    Steger, GG
    Zielinski, CC
    [J]. ANTI-CANCER DRUGS, 2000, 11 (03) : 149 - 153
  • [7] Docetaxel and cisplatin combination chemotherapy in Chinese patients with anthracycline-resistant advanced breast cancer
    Xu, B.
    Zhao, L.
    Wang, J.
    Yuan, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Docetaxel (D) and Gemcitabine (G) in anthracycline-resistant advanced breast cancer (AR-ABC)
    Fountzilas, G
    Bafaloukos, D
    Nikolaides, C
    Aravantinos, G
    Stathopoulos, G
    Apostolidou, K
    Kalofonos, H
    Kosmidis, P
    Pavlidis, N
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 26 - 26
  • [9] Biweekly docetaxel and vinorelbine in anthracycline-resistant metastatic breast cancer -: A multicenter phase II study
    Gómez-Bernal, A
    Cruz, JJ
    García-Palomo, A
    Arizcun, A
    Pujol, E
    Diz, P
    Martín, G
    Fonseca, E
    Sánchez, P
    Rodríguez, C
    del Barco, E
    López, Y
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02): : 127 - 131
  • [10] Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancer
    Spielmann, M
    Llombart, A
    Zelek, L
    Sverdlin, R
    Rixe, O
    Le Cesne, A
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (12) : 1457 - 1460
12345